CCL3 and myeloid sarcoma: CCR1 and its ligands CCL3, CCL5 and CCL7 have previously been shown to be expressed within inflammatory brain lesions in MS [18,39-41], and CCL3 has been demonstrated in cerebrospinal fluid of MS patients with relapsing-remitting disease course [42].